Study reveals factors influencing outcomes in kidney cancer treated with immunotherapy
(Dana-Farber Cancer Institute) By analyzing tumors from patients treated with immunotherapy for advanced kidney cancer in three clinical trials, Dana-Farber Cancer Institute scientists have identified several features of the tumors that influence their response to immune checkpoint inhibitor drugs.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
More News: Cancer | Cancer & Oncology | Clinical Trials | Immunotherapy | Kidney Cancer | Study | Urology & Nephrology